Hematology Center named after prof. R. Yeolyan
Yerevan, Armenia
3 recruiting
Showing 1–4 of 4 trials
Recruiting
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Immune Oncology Research Institute200 enrolled20 locationsNCT05430971
Recruiting
Phase 2
Assessment of the Safety and Efficacy of Balstilimab in Combination With Botensilimab for the Treatment of Non-Small Cell Lung Cancer (IMMONC0008)
Non-small Cell Lung Cancer
Immune Oncology Research Institute45 enrolled1 locationNCT06322108
Recruiting
Phase 2
Assessment of the Safety and Efficacy of Balstilimab for the Treatment of Relapsed/Refractory Lymphomas (IMMONC0001)
Lymphoma
Immune Oncology Research Institute20 enrolled1 locationNCT05891821
Recruiting
Rare Embryonal Tumors of the Central Nervous System: International Registry
Embryonal Tumor
Immune Oncology Research Institute300 enrolled11 locationsNCT05711992